Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21


Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.

Chaudhuri AA, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Khodadoust MS, Esfahani MS, Liu CL, Zhou L, Scherer F, Kurtz DM, Say C, Carter JN, Merriott DJ, Dudley JC, Binkley MS, Modlin L, Padda SK, Gensheimer MF, West RB, Shrager JB, Neal JW, Wakelee HA, Loo BW Jr, Alizadeh AA, Diehn M.

Cancer Discov. 2017 Dec;7(12):1394-1403. doi: 10.1158/2159-8290.CD-17-0716. Epub 2017 Sep 24.


Sinoatrial node toxicity after stereotactic ablative radiation therapy to lung tumors.

Qian Y, Zhu H, Pollom EL, Durkee BY, Chaudhuri AA, Gensheimer MF, Diehn M, Shultz DB, Loo BW Jr.

Pract Radiat Oncol. 2017 Nov - Dec;7(6):e525-e529. doi: 10.1016/j.prro.2017.04.005. Epub 2017 Apr 13.


Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung.

Binkley MS, King MT, Shrager JB, Bush K, Chaudhuri AA, Popat R, Gensheimer MF, Maxim PG, Henry Guo H, Diehn M, Nair VS, Loo BW Jr.

Radiother Oncol. 2017 May;123(2):270-275. doi: 10.1016/j.radonc.2017.03.021. Epub 2017 Apr 28.


Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR).

Chaudhuri AA, Binkley MS, Rigdon J, Carter JN, Aggarwal S, Dudley SA, Qian Y, Kumar KA, Hara WY, Gensheimer M, Nair VS, Maxim PG, Shultz DB, Bush K, Trakul N, Le QT, Diehn M, Loo BW Jr, Guo HH.

Radiother Oncol. 2016 Jun;119(3):454-60. doi: 10.1016/j.radonc.2016.05.007. Epub 2016 Jun 3.


Tracheal Diverticulum Following Paratracheal Hypofractionated Radiotherapy in the Setting of Prior and Subsequent Bevacizumab.

Chaudhuri AA, Chen JJ, Carter JN, Binkley MS, Kumar KA, Dudley SA, Sung AW, Loo BW Jr.

Cureus. 2016 Apr 19;8(4):e578. doi: 10.7759/cureus.578.


Atrial Myxoma Presenting as Myocardial Infarction Diagnosed by Echocardiography, Managed Endoscopically with Robot-Assisted Surgery.

Chaudhuri AA, Simmons C Jr, Ellison D, Hemp J, Chung K.

Cureus. 2016 Feb 7;8(2):e484. doi: 10.7759/cureus.484.


Concomitant Granulomatosis with Polyangiitis and C3 Glomerulonephritis Causing Renal Failure.

Chaudhuri AA, Davis JT.

Cureus. 2016 Feb 5;8(2):e482. doi: 10.7759/cureus.482.


Severe Chest Wall Toxicity From Cryoablation in the Setting of Prior Stereotactic Ablative Radiotherapy.

Chaudhuri AA, Binkley MS, Aggarwal S, Qian Y, Carter JN, Shah R, Loo BW Jr.

Cureus. 2016 Feb 2;8(2):e477. doi: 10.7759/cureus.477.


Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA.

Chaudhuri AA, Binkley MS, Osmundson EC, Alizadeh AA, Diehn M.

Semin Radiat Oncol. 2015 Oct;25(4):305-12. doi: 10.1016/j.semradonc.2015.05.001. Epub 2015 May 15. Review.


Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors.

Chaudhuri AA, Tang C, Binkley MS, Jin M, Wynne JF, von Eyben R, Hara WY, Trakul N, Loo BW Jr, Diehn M.

Lung Cancer. 2015 Jul;89(1):50-6. doi: 10.1016/j.lungcan.2015.04.014. Epub 2015 May 4.


Primary cutaneous diffuse large B cell lymphoma, leg type (PCDLBCL-LT) in the setting of prior radiation therapy.

Chaudhuri AA, Xavier MF.

J Gen Intern Med. 2015 Mar;30(3):371-2. doi: 10.1007/s11606-014-3047-y. Epub 2014 Oct 18. No abstract available.


Dual mechanisms by which miR-125b represses IRF4 to induce myeloid and B-cell leukemias.

So AY, Sookram R, Chaudhuri AA, Minisandram A, Cheng D, Xie C, Lim EL, Flores YG, Jiang S, Kim JT, Keown C, Ramakrishnan P, Baltimore D.

Blood. 2014 Aug 28;124(9):1502-12. doi: 10.1182/blood-2014-02-553842. Epub 2014 Jul 8.


MicroRNA-155 confers encephalogenic potential to Th17 cells by promoting effector gene expression.

Hu R, Huffaker TB, Kagele DA, Runtsch MC, Bake E, Chaudhuri AA, Round JL, O'Connell RM.

J Immunol. 2013 Jun 15;190(12):5972-80. doi: 10.4049/jimmunol.1300351. Epub 2013 May 17.


Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A.

Chaudhuri AA, So AY, Mehta A, Minisandram A, Sinha N, Jonsson VD, Rao DS, O'Connell RM, Baltimore D.

Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4233-8. doi: 10.1073/pnas.1200677109. Epub 2012 Feb 24.


MicroRNA-125b potentiates macrophage activation.

Chaudhuri AA, So AY, Sinha N, Gibson WS, Taganov KD, O'Connell RM, Baltimore D.

J Immunol. 2011 Nov 15;187(10):5062-8. doi: 10.4049/jimmunol.1102001. Epub 2011 Oct 14.


MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development.

O'Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, Chaudhuri AA, Kahn ME, Rao DS, Baltimore D.

Immunity. 2010 Oct 29;33(4):607-19. doi: 10.1016/j.immuni.2010.09.009. Epub 2010 Sep 30.


MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output.

O'Connell RM, Chaudhuri AA, Rao DS, Gibson WS, Balazs AB, Baltimore D.

Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14235-40. doi: 10.1073/pnas.1009798107. Epub 2010 Jul 26.


MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1.

Rao DS, O'Connell RM, Chaudhuri AA, Garcia-Flores Y, Geiger TL, Baltimore D.

Immunity. 2010 Jul 23;33(1):48-59. doi: 10.1016/j.immuni.2010.06.013. Epub 2010 Jul 1.


Physiological and pathological roles for microRNAs in the immune system.

O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D.

Nat Rev Immunol. 2010 Feb;10(2):111-22. doi: 10.1038/nri2708. Review.


Inositol phosphatase SHIP1 is a primary target of miR-155.

O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D.

Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7113-8. doi: 10.1073/pnas.0902636106. Epub 2009 Apr 9.


Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder.

O'Connell RM, Rao DS, Chaudhuri AA, Boldin MP, Taganov KD, Nicoll J, Paquette RL, Baltimore D.

J Exp Med. 2008 Mar 17;205(3):585-94. doi: 10.1084/jem.20072108. Epub 2008 Feb 25.

Supplemental Content

Loading ...
Support Center